{
    "nctId": "NCT00478686",
    "briefTitle": "Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine",
    "officialTitle": "A Retrospective Analysis of the Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 102,
    "primaryOutcomeMeasure": "Incidence of DPYD variants in patients",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patients must be registered for protocol ID 01-580 and only patients who were randomized to receive capecitabine will be included in the study.\n2. Patients must sign an informed consent for this protocol.\n\nExclusion Criteria:\n\n1) There are no exclusion criteria.",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}